Isaac  Zacharias net worth and biography

Isaac Zacharias Biography and Net Worth

Insider of Shockwave Medical
Isaac serves as Shockwave Medical’s Chief Commercial Officer overseeing global commercial activity from December 2018 following his role as GM for Structural Heart and VP of International Sales which began when he joined Shockwave in March 2018. Previously, Isaac served as the Vice President and General Manager for the PCI Guidance business at Boston Scientific where he led a turnaround of this franchise resulting in multiple consecutive years of revenue growth, share gain, and operating income leverage.

Prior to that, Isaac served as VP of New Business Development for Boston Scientific where he negotiated investments and acquisitions totaling more than $1 billion for the Cardiology, Rhythm Management, and Vascular business units. Isaac began his career as an R&D engineer and has held a variety of clinical and marketing roles.

Isaac earned his B.S. and M.S. degrees in Mechanical Engineering from the University of California, Davis.

What is Isaac Zacharias' net worth?

The estimated net worth of Isaac Zacharias is at least $18.50 million as of March 26th, 2024. Mr. Zacharias owns 56,818 shares of Shockwave Medical stock worth more than $18,501,645 as of March 29th. This net worth approximation does not reflect any other assets that Mr. Zacharias may own. Additionally, Mr. Zacharias receives an annual salary of $908,020.00 as Insider at Shockwave Medical. Learn More about Isaac Zacharias' net worth.

How old is Isaac Zacharias?

Mr. Zacharias is currently 49 years old. There are 5 older executives and no younger executives at Shockwave Medical. The oldest executive at Shockwave Medical is Mr. John M. Adams, Co-Founder and Technical Advisor, who is 77 years old. Learn More on Isaac Zacharias' age.

What is Isaac Zacharias' salary?

As the Insider of Shockwave Medical, Inc., Mr. Zacharias earns $908,020.00 per year. The highest earning executive at Shockwave Medical is Mr. Douglas E. Godshall M.B.A., President, CEO & Director, who commands a salary of $1,570,000.00 per year. Learn More on Isaac Zacharias' salary.

How do I contact Isaac Zacharias?

The corporate mailing address for Mr. Zacharias and other Shockwave Medical executives is 5403 Betsy Ross Drive, Santa Clara CA, 95054. Shockwave Medical can also be reached via phone at (877) 775-4846 and via email at [email protected]. Learn More on Isaac Zacharias' contact information.

Has Isaac Zacharias been buying or selling shares of Shockwave Medical?

During the last quarter, Isaac Zacharias has sold $3,090,880.00 in shares of Shockwave Medical stock. Most recently, Isaac Zacharias sold 4,000 shares of the business's stock in a transaction on Tuesday, March 26th. The shares were sold at an average price of $287.67, for a transaction totalling $1,150,680.00. Following the completion of the sale, the insider now directly owns 56,818 shares of the company's stock, valued at $16,344,834.06. Learn More on Isaac Zacharias' trading history.

Who are Shockwave Medical's active insiders?

Shockwave Medical's insider roster includes Colin Cahill (Director), Laura Francis (Director), Douglas Godshall (CEO), Antoine Papiernik (Director), Trinh Phung (VP), Dan Puckett (CFO), Maria Sainz (Director), Frank Watkins (Director), and Isaac Zacharias (Insider). Learn More on Shockwave Medical's active insiders.

Are insiders buying or selling shares of Shockwave Medical?

In the last year, insiders at the sold shares 47 times. They sold a total of 221,744 shares worth more than $52,184,011.04. The most recent insider tranaction occured on March, 26th when Director Laura Francis sold 1,500 shares worth more than $450,000.00. Insiders at Shockwave Medical own 3.4% of the company. Learn More about insider trades at Shockwave Medical.

Information on this page was last updated on 3/26/2024.

Isaac Zacharias Insider Trading History at Shockwave Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/26/2024Sell4,000$287.67$1,150,680.0056,818View SEC Filing Icon  
2/26/2024Sell4,000$260.36$1,041,440.0061,372View SEC Filing Icon  
1/26/2024Sell4,000$224.69$898,760.0063,920View SEC Filing Icon  
12/26/2023Sell4,000$192.50$770,000.0041,606View SEC Filing Icon  
11/27/2023Sell4,000$173.58$694,320.0043,868View SEC Filing Icon  
10/26/2023Sell4,000$210.25$841,000.0044,316View SEC Filing Icon  
9/26/2023Sell4,000$192.12$768,480.0047,905View SEC Filing Icon  
8/25/2023Sell4,000$204.98$819,920.0052,446View SEC Filing Icon  
7/26/2023Sell4,000$268.06$1,072,240.0056,678View SEC Filing Icon  
6/26/2023Sell4,000$291.84$1,167,360.0060,678View SEC Filing Icon  
5/26/2023Sell4,000$277.53$1,110,120.0065,223View SEC Filing Icon  
4/26/2023Sell4,000$289.00$1,156,000.0069,454View SEC Filing Icon  
3/27/2023Sell4,000$215.69$862,760.0074,078View SEC Filing Icon  
2/27/2023Sell4,000$188.51$754,040.0064,619View SEC Filing Icon  
1/26/2023Sell4,000$192.77$771,080.0069,021View SEC Filing Icon  
12/27/2022Sell4,000$209.59$838,360.0073,021View SEC Filing Icon  
11/25/2022Sell4,000$261.82$1,047,280.0073,021View SEC Filing Icon  
10/26/2022Sell4,000$292.44$1,169,760.0073,021View SEC Filing Icon  
9/26/2022Sell4,000$250.07$1,000,280.0073,021View SEC Filing Icon  
8/26/2022Sell4,000$308.25$1,233,000.0073,563View SEC Filing Icon  
7/26/2022Sell4,000$208.28$833,120.0074,563View SEC Filing Icon  
6/27/2022Sell4,000$198.00$792,000.0078,563View SEC Filing Icon  
4/29/2022Sell619$160.36$99,262.8465,221View SEC Filing Icon  
4/26/2022Sell3,370$183.76$619,271.2065,840View SEC Filing Icon  
3/28/2022Sell4,000$188.83$755,320.00View SEC Filing Icon  
2/15/2022Sell4,000$149.96$599,840.00View SEC Filing Icon  
2/2/2022Sell1,617$153.63$248,419.71View SEC Filing Icon  
1/14/2022Sell4,000$175.37$701,480.00View SEC Filing Icon  
12/15/2021Sell4,000$172.73$690,920.00View SEC Filing Icon  
10/15/2021Sell4,000$194.18$776,720.00View SEC Filing Icon  
9/15/2021Sell4,000$220.75$883,000.0059,320View SEC Filing Icon  
8/16/2021Sell4,000$186.97$747,880.0060,983View SEC Filing Icon  
7/15/2021Sell4,000$165.49$661,960.0063,420View SEC Filing Icon  
6/15/2021Sell4,000$188.25$753,000.0063,420View SEC Filing Icon  
5/14/2021Sell4,000$148.18$592,720.0054,420View SEC Filing Icon  
4/15/2021Sell4,000$138.57$554,280.0055,050View SEC Filing Icon  
3/15/2021Sell4,000$114.70$458,800.0055,050View SEC Filing Icon  
2/16/2021Sell4,000$132.39$529,560.0062,550View SEC Filing Icon  
1/15/2021Sell4,000$136.16$544,640.0061,282View SEC Filing Icon  
12/15/2020Sell4,000$92.91$371,640.0062,550View SEC Filing Icon  
11/16/2020Sell4,000$94.17$376,680.0062,550View SEC Filing Icon  
10/15/2020Sell4,000$73.24$292,960.0062,550View SEC Filing Icon  
9/10/2020Sell4,000$66.61$266,440.0062,550View SEC Filing Icon  
7/10/2020Sell4,000$43.19$172,760.0038,567View SEC Filing Icon  
6/10/2020Sell4,000$46.90$187,600.0038,567View SEC Filing Icon  
5/11/2020Sell4,000$41.13$164,520.0038,567View SEC Filing Icon  
4/13/2020Sell4,000$35.34$141,360.0039,000View SEC Filing Icon  
3/10/2020Sell4,000$36.61$146,440.0039,000View SEC Filing Icon  
2/10/2020Sell4,000$44.96$179,840.009,000View SEC Filing Icon  
1/10/2020Sell4,000$44.78$179,120.009,000View SEC Filing Icon  
12/10/2019Sell4,000$40.24$160,960.009,000View SEC Filing Icon  
11/11/2019Sell4,000$35.66$142,640.009,000View SEC Filing Icon  
10/11/2019Sell4,000$32.68$130,720.00
See Full Table

Isaac Zacharias Buying and Selling Activity at Shockwave Medical

This chart shows Isaac Zacharias's buying and selling at Shockwave Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Shockwave Medical Company Overview

Shockwave Medical logo
Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
Read More

Today's Range

Now: $325.63
Low: $322.61
High: $331.58

50 Day Range

MA: $254.81
Low: $217.19
High: $325.63

2 Week Range

Now: $325.63
Low: $157.00
High: $331.58

Volume

814,504 shs

Average Volume

698,070 shs

Market Capitalization

$12.18 billion

P/E Ratio

84.14

Dividend Yield

N/A

Beta

0.9